Cargando…

Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model

BACKGROUND: Honokiol is a major bioactive compound extracted from Magnolia. The present study was designed to determine whether liposomal honokiol has the antitumor activity against human lung cancer as well as potentiates the antitumor activity of cisplatin in A549 lung cancer xenograft model, if s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Qi-qi, Fan, Lin-yu, Yang, Guang-li, Guo, Wen-Hao, Hou, Wen-li, Chen, Li-juan, Wei, Yu-quan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543046/ https://www.ncbi.nlm.nih.gov/pubmed/18706101 http://dx.doi.org/10.1186/1471-2407-8-242

Ejemplares similares

Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
por: Li, Shenglan, et al.
Publicado: (2021)

Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis
por: Li, Xin, et al.
Publicado: (2023)

Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutant
por: Yu, Dan-Dan, et al.
Publicado: (2010)

Counteracting Cisplatin-Induced Testicular Damages by Natural Polyphenol Constituent Honokiol
por: Wang, Tse-En, et al.
Publicado: (2020)

HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma
por: Zhang, Xiangxiang, et al.
Publicado: (2022)

Honokiol improves depression-like behaviors in rats by HIF-1α- VEGF signaling pathway activation
por: Fan, Xiao-Xu, et al.
Publicado: (2022)

Erratum to liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
Publicado: (2023)

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration
por: Yu, Chung-Ping, et al.
Publicado: (2021)

Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma
por: Li, Shenglan, et al.
Publicado: (2022)

The application prospects of honokiol in dermatology
por: Li, Yao, et al.
Publicado: (2022)

Honokiol Improves Liver Steatosis in Ovariectomized Mice
por: Jeong, Yeon-Hui, et al.
Publicado: (2018)

Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
por: Yang, Jianhong, et al.
Publicado: (2016)

Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
por: Yang, Jianhong, et al.
Publicado: (2020)

Nanoparticulated Honokiol Mitigates Cisplatin-Induced Chronic Kidney Injury by Maintaining Mitochondria Antioxidant Capacity and Reducing Caspase 3-Associated Cellular Apoptosis
por: Liu, Hung-Ting, et al.
Publicado: (2019)

Honokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats
por: Hsu, Chuan-Chih, et al.
Publicado: (2014)

In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
por: Zuo, Guo-Ying, et al.
Publicado: (2015)

Honokiol and Magnolol as Multifunctional Antioxidative Molecules for Dermatologic Disorders
por: Shen, Jui-Lung, et al.
Publicado: (2010)

Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells
por: Luo, Lian-Xiang, et al.
Publicado: (2017)

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016)

Honokiol, a Polyphenol Natural Compound, Attenuates Cisplatin-Induced Acute Cytotoxicity in Renal Epithelial Cells Through Cellular Oxidative Stress and Cytoskeleton Modulations
por: Wang, Tse-En J., et al.
Publicado: (2018)

Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC)
por: Feng, Yuan, et al.
Publicado: (2023)

Neuro-Modulating Effects of Honokiol: A Review
por: Woodbury, Anna, et al.
Publicado: (2013)

Antineoplastic Effects of Honokiol on Melanoma
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2017)

Honokiol: A Review of Its Anticancer Potential and Mechanisms
por: Ong, Chon Phin, et al.
Publicado: (2019)

SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis
por: Chen, Xiaotian, et al.
Publicado: (2023)

Honokiol in glioblastoma recurrence: a case report
por: Wang, Ce, et al.
Publicado: (2023)

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
por: Stathopoulos, G. P., et al.
Publicado: (2010)

Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway
por: Liu, Guang Zhong, et al.
Publicado: (2022)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

Honokiol attenuate the arsenic trioxide‐induced cardiotoxicity by reducing the myocardial apoptosis
por: Huang, An‐Liang, et al.
Publicado: (2022)

Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid–cisplatin-based liposomes
por: Song, Juan, et al.
Publicado: (2017)

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016)

The Effects of Rhein and Honokiol on Metabolic Profiles in a Mouse Model of Acute Pancreatitis
por: Huang, Wei, et al.
Publicado: (2020)

Combination of BFHY with Cisplatin Relieved Chemotherapy Toxicity and Altered Gut Microbiota in Mice
por: Feng, Yuan, et al.
Publicado: (2023)

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
por: Liu, Minghui, et al.
Publicado: (2021)

Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain
por: Lin, Yi-Ruu, et al.
Publicado: (2009)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
por: Trifan, Adriana, et al.
Publicado: (2021)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9pgkltev1u5fr7pouurrs1emn7